The Effect of International Travel Arrivals on the New HIV Infections in 15-49 Years Aged Group Among 109 Countries or Territories From 2000 to 2018
- PMID: 35252102
- PMCID: PMC8888525
- DOI: 10.3389/fpubh.2022.833551
The Effect of International Travel Arrivals on the New HIV Infections in 15-49 Years Aged Group Among 109 Countries or Territories From 2000 to 2018
Abstract
Objective: The prevalent international travel may have an impact on new HIV infections, but related studies were lacking. We aimed to explore the association between international travel arrivals and new HIV infections in 15-49 years aged group from 2000 to 2018, to make tailored implications for HIV prevention.
Methods: We obtained the data of new HIV infections from the Joint United Nations Programme on HIV/AIDS and international travel arrivals from the World Bank. Correlation analysis was used to explore the relation briefly. Log-linear models were built to analyze the association between international travel arrivals and new HIV infections.
Results: International travel arrivals were positively correlated with new HIV infections (correlation coefficients: 0.916, p < 0.001). After controlling population density, the median age of the total population (years), socio-demographic index (SDI), travel-related mandatory HIV testing, HIV-related restrictions, and antiretroviral therapy coverage, there were 6.61% (95% CI: 5.73, 7.50; p < 0.001) percentage changes in new HIV infections of 15-49 years aged group associated with a 1 million increase in international travel arrivals.
Conclusions: Higher international travel arrivals were correlated with new HIV infections in 15-49 years aged group. Therefore, multipronged structural and effective strategies and management should be implemented and strengthened.
Keywords: 15–49 years; AIDS; HIV; risk; travel.
Copyright © 2022 Du, Yuan, Jing, Liu and Liu.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
HIV-related travel restrictions: trends and country characteristics.Glob Health Action. 2013 Jun 3;6:20472. doi: 10.3402/gha.v6i0.20472. Glob Health Action. 2013. PMID: 23735755 Free PMC article.
-
Travel, migration and HIV.AIDS Care. 1993;5(2):207-14. doi: 10.1080/09540129308258601. AIDS Care. 1993. PMID: 8329484
-
Surveillance for travel-related disease--GeoSentinel Surveillance System, United States, 1997-2011.MMWR Surveill Summ. 2013 Jul 19;62:1-23. MMWR Surveill Summ. 2013. PMID: 23863769
-
HIV prevention among injecting drug users: responses in developing and transitional countries.Public Health Rep. 1998 Jun;113 Suppl 1(Suppl 1):170-81. Public Health Rep. 1998. PMID: 9722822 Free PMC article. Review.
-
HIV infection and international travel.Prof Nurse. 2000 Apr;15(7):453-6. Prof Nurse. 2000. PMID: 11129928 Review.
Cited by
-
Mesenchymal Stem Cells and MSCs-Derived Extracellular Vesicles in Infectious Diseases: From Basic Research to Clinical Practice.Bioengineering (Basel). 2022 Nov 8;9(11):662. doi: 10.3390/bioengineering9110662. Bioengineering (Basel). 2022. PMID: 36354573 Free PMC article. Review.
-
Human immunodeficiency virus epidemic scenery among brazilian women: a spatial analysis study.BMC Womens Health. 2023 Sep 1;23(1):463. doi: 10.1186/s12905-023-02616-5. BMC Womens Health. 2023. PMID: 37658362 Free PMC article.
References
-
- World Health Organization. HIV/AIDS. (2021). Available online at: https://www.who.int/health-topics/hiv-aids#tab=tab_2 (accessed May 17, 2021).
-
- Bisson GP, Bastos M, Campbell JR, Bang D, Brust JC, Isaakidis P, et al. . Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis. Lancet. (2020) 396:402–11. 10.1016/S0140-6736(20)31316-7 - DOI - PMC - PubMed
-
- Hosseinipour MC, Bisson GP, Miyahara S, Sun X, Moses A, Riviere C, et al. . Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial. Lancet. (2016) 387:1198–209. 10.1016/S0140-6736(16)00546-8 - DOI - PMC - PubMed
-
- Gupta-Wright A, Corbett EL, van Oosterhout JJ, Wilson D, Grint D, Alufandika-Moyo M, et al. . Rapid urine-based screening for tuberculosis in HIV-positive patients admitted to hospital in Africa (STAMP): a pragmatic, multicentre, parallel-group, double-blind, randomised controlled trial. Lancet. (2018) 392:292–301. 10.1016/S0140-6736(18)31267-4 - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical